Paper Publications
- [1] 张雪. What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis. Frontiers in Immunology, 13, 2022.
- [2] 徐谦. Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. Frontiers in Immunology, 12, 2021.
| TOTAL 2 PIECE 1/1 | FIRSTPREVIOUSNEXTLAST |
 |
- 王健
|
Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100 Information desk: (86) - 0531-88395114 On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University |
Click:
 MOBILE Version
The Last Update Time:.. |